Evaluation of cis-Platinum and DTIC Combination Chemotherapy in Disseminated Melanoma A Southwest Oncology Group Study
William S. Fletcher(Oregon Health & Science University), RaeAnn Townsend(J.P. Morgan), Stephanie Green(University of Alberta), J R Fletcher(J.P. Morgan), Bruce W. Dana(Unknown), William R. Jewell(J.P. Morgan)
Cited by 27
Related Papers
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.
|Journal of Clinical Oncology|1991|383
Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.
|Journal of Clinical Oncology|1993|193
Developments in the diagnosis and treatment of primary CNS lymphoma: A prospective series
|Cancer|1986|123